A general and simple diastereoselective reduction by l-selectride: Efficient synthesis of protected (4s,5s)-dihydroxy Amides

Article abstract of DOI:10.3390/molecules15042771

A general approach to (4S,5S)-4-benzyloxy-5-hydroxy-N-(4-methoxybenzyl) amides 10 based on a diastereoselective reduction of (5S,6RS)-6-alkyl-5- benzyloxy-6hydroxy-2-piperidinones 6 and their tautomeric ring-opened keto amides 7 is described. The reduction with L-Selectride at -20 °C to room temperature afforded the products 10 in excellent yields and moderate to high syn-diastereoselectivities. Copyright

Full text of DOI:10.3390/molecules15042771

Molecules 2010, 15, 2771-2781; doi:10.3390/molecules15042771
OPEN ACCESS
molecules
ISSN 1420-3049
www.mdpi.com/journal/molecules
Article
A General and Simple Diastereoselective Reduction by
L-Selectride: Efficient Synthesis of Protected (4S,5S)-Dihydroxy
Amides
Bo Yin, Dong-Nai Ye, Kai-Hui Yu and Liang-Xian Liu *
Department of Chemistry and Biology, Ganan Normal University, Ganzhou, Jiangxi 341000, China
* Author to whom correspondence should be addressed; E-Mail: lxliu@xmu.edu.cn; Tel: +86-797-
8397630; Fax: +86-797-8393670.
Received: 18 December 2009; in revised form: 24 March 2010 / Accepted: 12 April 2010 /
Published: 16 April 2010
Abstract: A general approach to (4S,5S)-4-benzyloxy-5-hydroxy-N-(4-methoxybenzyl)
amides 10 based on a diastereoselective reduction of (5S,6RS)-6-alkyl-5-benzyloxy-6-
hydroxy-2-piperidinones 6 and their tautomeric ring-opened keto amides 7 is described.
The reduction with L-Selectride at -20 °C to room temperature afforded the products 10 in
excellent yields and moderate to high syn-diastereoselectivities.
Keywords: L-Selectride; 3-hydroxyglutarimide; (4S,5S)-dihydroxyamide
1. Introduction
The (4,5)-dihydroxycarboxylate moiety is a critical framework shared by many bioactive
compounds, such as Microcarpalide (1), which is a 10-membered lactone that was isolated from the
fermentation broth of an unidentified endophytic fungus by Hemscheidt and co-workers in 2001 [1],
and Kalanchosine dimalate (KMC, 2) [2], which is an anti-inflammatory salt from the fresh juice of the
aerial parts of Kalanchoe brasiliensis, as well as natural gastroprotective 3,4-dihydroisocoumarins,
such as amicoumacin C (3) [3,4] and AI-77B (4) [5,6]. Both the stereochemical variation at C-4, C-5
and the interesting biological activities exhibited by these compounds make them attractive synthetic
targets [1,5-7]. A number of methods have been developed for the synthesis of these compounds [8-
13], but few methods for the construction of the (4,5)-dihydroxycarboxylate moiety [14-18].

Molecules 2010, 15
2772
Generally, chiral pool starting materials or Sharpless asymmetric dihydroxylation was used in the
construction of the (4,5)-dihydroxycarboxylate moiety.
Figure 1. (4,5)-Dihydroxycarboxylate derivatives.
OH
R
OH
OH
O
O
NH2 OH
R
HO
OH
n-C6H13
OH
HO
O
O
O
OH NH2
O
x2
OH
KMC (2)
OH
(-)-Microcarpalide (1)
OH
O
O
O
OH NH2
S
O
OH
S
NH2HCl
O
H
N
H
N
S
S
O
OH CO2H
O
O
Amicoumacin (3)
Al-77B (4)
Previously, we have shown that the protected (S)-3-hydroxyglutarimide 5 may serve as a versatile
building block for the asymmetric synthesis of a variety of 2,6-disubstituted 3-hydroxypiperidines
[19-23]. A flexible regio- and diastereoselective reductive alkylation method was developed for the
conversion of 5 to trans-6-alkyl-5-benzyloxy-2-piperidinone derivatives 8 [20]. Recently, we also
developed a chemo- and diastereoselective transformation of the N,O-acetals 6 and their chain
tautomers 7, readily derived from protected 3-hydroxyglutarimide 5, into cyclic products (5S,6S/R)-6-
alkyl-5-benzyloxy-2-piperidinones 9/8, and anti-10/syn-10 with a combination of boron trifluoride
etherate/zinc borohydride in modest chemo- and diastereoselectivities (Scheme 1) [24]. Moreover, the
reduction with zinc borohydride in the absence of BF3•OEt2 leading exclusively to the formation of the
ring-opening products anti-10 in excellent anti-diastereoselectivities was exploited. In addition, we
reported the application of this new variation to the asymmetric synthesis of (+)-azimic acid [25].
Scheme 1. The synthesis of 6-alkyl-5-benzyloxy-2-piperidinones.
OBn
RMgX
OBn
OH
O
O
R
HN
PMB
O
N
O
O
N
R
OBn
PMB
5
PMB
6
7
R=alkyl, aryl, arylalkyl
OBn
+ 9
Et3SiH
O
O
N
R
BF3 OEt2
PMB
8
trans:cis = 92:8 - 98:2
6 + 7
OBn
+ 8
O
OH
Zn(BH4)2
BF3 OEt2
+
+ syn-10
R
HN
PMB
anti-10
anti:syn = 55:45 - 100:0
N
R
OBn
PMB
9
cis:trans = 60:40 - 100:0

Molecules 2010, 15
2773
In the continuation of our interest in the amino acid chiral template-assisted synthesis of natural and
unnatural bioactive compounds, as a part of our research program aimed at developing enantioselective
syntheses of naturally occurring bioactive compounds, such as Microcarpalide (1), we decided to
explore the construction of the (4,5)-dihydroxycarboxylate moiety in order to develop a simple and
feasible approach to syn-10, a key intermediate (R = CH=CH2) for the synthesis of 1. Herein we report
a diastereoselective reduction of 6 and 7 employing L-Selectride as the reductive agent to obtain syn-
10 (Scheme 2).
2. Results and Discussion
The requisite 6-alkyl-5-benzyloxy-6-hydroxy-2-piperidinones 6, together with their ring-opened
keto amide tautomers 7, were prepared via the addition of Grignard reagents to (S)-3-benzyloxy-
glutarimide 5 under our recently improved conditions [23]. Treatment of the tautomeric mixture of 6a
and 7a with 1.2 molar equiv of L-Selectride in THF (−20 °C - rt) yielded syn-10a and anti-10a in a
ratio of 86:14 (combined yield: 93%). To explore the generality of the process, a series of hemi-
azaketals 6 and their opened keto amide tautomers 7 were investigated using L-Selectride as reductive
agent [26-29], and the results are reported in Table 1.
Scheme 2. The diastereoselective reduction by L-Selectride.
OBn
O
O
O
OH
O
OH
L-Selectride
-20 oC - rt
OH
+
+
HN
PMB
R
HN
PMB
anti-10
R
O
N
HN
PMB
syn-10
R
R
OBn
OBn
PMB
6
OBn
7
Table 1. Results of reduction according to the procedure shown in Scheme 2.
Entry
R
Yield [%] a
syn/anti ratio
6:1 b
1
2
3
4
5
6
7
8
9
CH3 (10a)
93
97
97
95
98
85
83
92
81
92
C2H5 (10b)
n-C4H9 (10c)
n-C5H11 (10d)
n-C8H17 (10e)
n-C12H25 (10f)
n-C16H33 (10g)
i-Bu (10h)
Ph (10i)
Bn (10j)
PhCH2CH2 (10k)
7:1 c
7:1 c
23:2 c
23:2 b
9:1 b
7:1 b
3:1 c
3:1 b
10
11
11:2 c
82
7:2 c
a
b
1
Isolated yield of 10 starting from 6 and 7. Ratio determined by H-
NMR analysis. c Ratio based on HPLC analysis.
As can be seen from Table 1, high yields and modest to high syn-selectivities were obtained for all
hemi-azaketals tested. It is interesting to note that modest syn-selectivities were obtained in the case
where 6 and 7 bearing i-Bu or Ph (Table 1, entries 8 and 9) as well as PhCH2CH2 (Table 1, entry 11).

Molecules 2010, 15
2774
The stereochemistry of the major diastereomer 10 was assigned to syn-conformer according to the
observed vicinal coupling constants [24] (J4,5 = 5.1 Hz for syn-10a and J4,5 = 4.5 Hz for anti-10a; J4,5 =
5.2 Hz for syn-10b and J4,5 = 4.3 Hz for anti-10b; J4,5 = 5.1 Hz for syn-10c and J4,5 = 4.2 Hz for anti-
10c; J4,5 = 5.1 Hz for syn-10e and J4,5 = 4.4 Hz for anti-10e; J4,5 = 5.1 Hz for syn-10g and J4,5 = 4.5 Hz
for anti-10g; J4,5 = 6.1 Hz for syn-10i and J4,5 = 5.1 Hz for anti-10i). In addition, the stereochemistry of
diastereomers syn-10 was confirmed by converting syn-10 to (5S,6R)-6-alkyl-5-benzyloxy-2-piperidin-
ones 8. For example, syn-10a can be converted to anti-8a in 78% yield by mesylation (MsCl, Et3N,
CH2Cl2, −20 °C, 1 h) and t-BuOK-promoted cyclization (HMPA, THF, rt, 24 h) (Scheme 3).
Scheme 3. The synthesis of (5S,6R )-6-methyl-5-benzyloxy-2-piperidinones.
O
OH
CH3
OBn
CH3
O
OMs
CH3
MsCl, Et3N
-20 oC
t-BuOK
HN
PMB
syn-10a
HN
PMB
11
O
N
HMPA, rt
OBn
OBn
PMB
(5S,6R)-8a
Figure 2. A plausible Cram chelation-controlled pathway for the syn-diastereoselective
formation of syn-10.
OBn
OH
O
O
L-Selectride
HN
R
O
N
R
PMB
OBn
PMB
6
s-Bu
7
Bu-s
Bu-s
Li+
B
O
R
H
O
OH
OBn
H
HN
R
PMB
OBn
PMBHN
syn-10
O
The fact that starting from the tautomeric mixture of 6 and 7 syn-diastereomer 10 was obtained in
modest to high diastereoselectivity is in accordance with a Cram model-based mechanism [30-34]. It
was envisioned that the hydride to approach C-5 carbon from the same side of the chelate C-4
benzyloxy substituent led to the formation of syn-isomer because of the chelation between lithium ion
and oxygen atom of the C-4 oxygen as well as C-5 carbonyl oxygen (Figure 2), which not only
switches the equilibrium towards 7, but also allows the reduction to undergo with a Cram chelation-
controlled manner.
3. Conclusions
In summary, a simple and efficient route to protected (4S,5S)-dihydroxy amides via the reduction of
the tautomeric mixture of 6 and 7 with L-Selectride has been developed. This strategy offers a concise
platform for the construction of (4S,5S)-dihydroxycarboxylate moieties under mild conditions. As

Molecules 2010, 15
2775
such, this method is complementary, in part, to our previously established anti-diastereoselective
method.
4. Experimental
4.1. General methods
Melting points were determined on a Yanaco MP-500 micro melting point apparatus and are
uncorrected. Infrared spectra were measured with a Nicolet Avatar 360 FT-IR spectrometer using film
1
KBr pellet technique. H-NMR spectra were recorded in CDCl3 on a Bruker 400 or a Varian unity
+500 spectrometer with tetramethylsilane as an internal standard. Chemical shifts are expressed in δ
(ppm) units downfield from TMS. Mass spectra were recorded with Bruker Dalton Esquire 3000 plus
LC-MS apparatus. Optical rotations were measured with a Perkin-Elmer 341 automatic polarimeter.
Elemental analysis was carried out on a Perkin-Elmer 240B instrument. Flash column chromatography
was carried out with silica gel (300-400 mesh). THF was distilled over sodium and CH2Cl2 was
distilled over P2O5 under N2.
4.2. General procedure for preparation of syn-10
To a cooled (−20 °C) solution of tautomeric mixture 6/7 [20] (1.0 mol equiv) in THF (0.1 M) was
added dropwise a solution of L-Selectride (1.2 mol equiv) under argon atmosphere and the mixture was
stirred at −20 ~ −10 °C for 1 h. Then, the mixture was allowed to slowly warm to room temperature
and was stirred at room temperature overnight. The reaction was quenched with a saturated aqueous
NH4Cl. After extraction with CH2Cl2, the combined organic layers were washed with brine, dried over
anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by
flash chromatography on silica gel (eluent: EtOAc/Petroleum ether = 1:2), some pure syn-10 and the
mixture of syn-10 and anti-10 were obtained.
(4S,5S)-4-Benzyloxy-5-hydroxy-N-(4-methoxybenzyl)hexanoyl amide (syn-10a): White solid, mp: 74-
1
75 °C; [α]25D: +4.75 (c 1.0, CHCl3); IR (film) νmax: 3407, 3305, 1649, 1513, 1248 cm-1; H-NMR
(400 MHz, CDCl3): δ 7.33-7.25 (m, 5H, Ar-H), 7.15 (d, J = 8.6 Hz, 2H, Ar-H), 6.83 (d, J = 8.6 Hz,
2H, Ar-H), 5.60 (s, 1H, NH), 4.59 (d, J = 11.5 Hz, 1H, OCH2), 4.53 (d, J = 11.5 Hz, 1H, OCH2), 4.32
(dd, J = 14.5, 5.6 Hz, 1H, NCH2), 4.27 (dd, J = 14.5, 5.6 Hz, 1H, NCH2), 3.78 (s, 3H, OCH3), 3.70 (m,
1H, H-4), 3.35 (dd, J = 6.4, 5.1 Hz, 1H, H-5), 2.59 (d, J = 2.8 Hz, 1H, OH), 2.25 (t, J = 7.4 Hz, 2H, H-
2), 2.04 (ddd, J = 14.0, 7.4, 4.9 Hz, 1H, H-6), 1.82 (ddd, J = 14.0, 7.4, 6.8 Hz, 1H, H-3), 1.17 (t,
J = 6.4 Hz, 3H, CH3); 13C-NMR (100 MHz, CDCl3): δ 172.4 (C=O), 158.9, 138.2, 130.3, 129.1 (2×C),
128.4 (2×C), 127.9 (2×C), 127.8, 114.0 (2×C), 82.1 (C-5), 71.9 (C-4), 68.6 (OCH2), 55.2 (OCH3), 43.0
(NCH2), 31.6, 25.6, 18.9; MS (ESI): 358 [M+H]+, 380 [M+Na]+; Anal calcd for C21H27NO4: C, 70.56;
H, 7.61; N, 3.92. Found C, 70.31; H, 7.76; N, 4.25.
(4S,5S)-4-Benzyloxy-5-hydroxy-N-(4-methoxybenzyl)heptanoyl amide (syn-10b): White solid, mp: 122-
1
124 °C; [α]25D: +1.86 (c 1.2, CHCl3); IR (film) νmax: 3407, 3306, 1649, 1513, 1248 cm-1; H-NMR
(400 MHz, CDCl3): δ 7.32-7.25 (m, 5H, Ar-H), 7.15 (d, J = 8.7 Hz, 2H, Ar-H), 6.83 (d, J = 8.7 Hz,

Molecules 2010, 15
2776
2H, Ar-H), 5.57 (s, 1H, NH), 4.59 (d, J = 11.5 Hz, 1H, OCH2), 4.53 (d, J = 11.5 Hz, 1H, OCH2), 4.32
(dd, J = 14.4, 5.5 Hz, 1H, NCH2), 4.28 (dd, J = 14.5, 5.5 Hz, 1H, NCH2), 3.78 (s, 3H, OCH3), 3.43 (m,
1H, H-4), 3.36 (ddd, J = 5.6, 5.6, 5.2 Hz, 1H, H-5), 2.42 (s, 1H, OH), 2.26 (t, J = 7.4 Hz, 2H, H-3),
2.03 (ddd, J = 13.8, 7.1, 5.2 Hz, 1H, H-2), 1.87 (ddd, J = 13.8, 7.5, 7.2 Hz, 1H, H-2), 1.55 (ddd,
J = 13.8, 7.5, 4.1 Hz, 1H, H-6), 1.46 (ddd, J = 13.8, 7.2, 5.2 Hz, 1H, H-6), 0.95 (t, J = 7.5 Hz, 3H,
13
CH3); C-NMR (100 MHz, CDCl3): δ 172.4 (C=O), 158.9, 138.2, 130.4, 129.1 (2×C), 128.4 (2×C),
127.8 (2×C), 127.7, 114.0 (2×C), 80.8 (C-5), 74.0 (C-4), 72.5 (OCH2), 55.2 (OCH3), 43.0 (NCH2),
31.8, 26.2, 25.9, 10.2; MS (ESI): 371 [M+H]+, 394 [M+Na]+, 410 [M+K]+; Anal calcd for C22H29NO4:
C, 71.13; H, 7.87; N, 3.77. Found C, 71.03; H, 7.55; N, 3.71.
(4S,5S)-4-Benzyloxy-5-hydroxy-N-(4-methoxybenzyl)nonanoyl amide (syn-10c): Waxy solid; [α]25
:
D
+1.90 (c 1.5, CHCl3); IR (film) νmax: 3407, 3305, 1650, 1513, 1248 cm-1; 1H-NMR (500 MHz, CDCl3):
δ 7.35-7.25 (m, 5H, Ar-H), 7.16 (d, J = 8.7 Hz, 2H, Ar-H), 6.84 (d, J = 8.7 Hz, 2H, Ar-H), 5.55 (s, 1H,
NH), 4.60 (d, J = 11.5 Hz, 1H, OCH2), 4.53 (d, J = 11.5 Hz, 1H, OCH2), 4.33 (dd, J = 14.4, 5.6 Hz,
1H, NCH2), 4.28 (dd, J = 14.4, 5.6 Hz, 1H, NCH2), 3.78 (s, 3H, OCH3), 3.52 (m, 1H, H-4), 3.36 (ddd,
J = 6.2, 5.1, 5.1 Hz, 1H, H-5), 2.33 (s, 1H, OH), 2.26 (t, J = 7.4 Hz, 2H, H-2), 2.05 (ddd, J = 14.0, 7.4,
5.2 Hz, 1H, H-3), 1.87 (ddd, J = 14.0, 7.6, 7.4 Hz, 1H, H-3), 1.52-1.40 (m, 3H), 1.36-1.25 (m, 3H),
0.89 (t, J = 7.1 Hz, 3H, CH3); 13C-NMR (125 MHz, CDCl3): δ 172.4 (C=O), 159.0, 138.2, 130.3, 129.2
(2×C), 128.4 (2×C), 127.9 (2×C), 127.8, 114.0 (2×C), 81.1 (C-5), 72.6 (C-4), 72.5 (OCH2), 55.3
(OCH3), 43.1 (NCH2), 33.1, 31.8, 27.9, 23.9, 22.7, 14.0; MS (ESI): 400 [M+H]+, 422 [M+Na]+, 438
[M+K]+; Anal calcd for C24H33NO4: C, 72.15; H, 8.33; N, 3.51. Found C, 72.34; H, 8.36; N, 3.66.
(4S,5S)-4-Benzyloxy-5-hydroxy-N-(4-methoxybenzyl)decanoyl amide (syn-10d): Waxy solid;
1
[α]25D: -1.76 (c 2.3, CHCl3); IR (film) νmax: 3411, 3304, 2931, 1646, 1513, 1248 cm-1; H-NMR (400
MHz, CDCl3): δ 7.32-7.26 (m, 5H, Ar-H), 7.15 (d, J = 8.5 Hz, 2H, Ar-H), 6.82 (d, J = 8.5 Hz, 2H, Ar-
H), 5.85 (s, 1H, NH), 4.59 (d, J = 11.5 Hz, 1H, OCH2), 4.52 (d, J = 11.5 Hz, 1H, OCH2), 4.32 (dd,
J = 14.5, 5.6 Hz, 1H, NCH2), 4.28 (dd, J = 14.5, 5.6 Hz, 1H, NCH2), 3.78 (s, 3H, OCH3), 3.52 (m, 1H,
H-4), 3.34 (ddd, J = 5.4, 5.4, 5.2 Hz, 1H, H-5), 2.38 (d, J = 4.3 Hz, 1H, OH), 2.25 (t, J = 7.3 Hz, 2H,
H-2), 2.04 (ddd, J = 14.0, 7.7, 7.3 Hz, 1H, H-3), 1.87 (ddd, J = 14.0, 7.3, 7.1 Hz, 1H, H-3), 1.50-1.40
13
(m, 3H), 1.35-1.20 (m, 5H), 0.88 (t, J = 6.8 Hz, 3H, CH3); C-NMR (100 MHz, CDCl3): δ 172.4
(C=O), 159.0, 138.2, 130.4, 129.1 (2×C), 128.4 (2×C), 127.9 (2×C), 127.8, 114.0 (2×C), 81.1 (C-5),
72.6 (C-4), 72.5 (OCH2), 55.2 (OCH3), 43.0 (NCH2), 33.3, 31.8, 26.0, 25.4 (2×C), 22.6, 14.0; MS
(ESI): 414 [M+H]+, 436 [M+Na]+; Anal calcd for C25H35NO4: C, 72.61; H, 8.53; N, 3.39. Found C,
72.33; H, 8.52; N, 3.42.
(4S,5S)-4-Benzyloxy-5-hydroxy-N-(4-methoxybenzyl)tridecanoyl amide (syn-10e): Waxy solid;
[α]25D: -2.21 (c 2.3, CHCl3); IR (film) νmax: 3406, 3304, 2926, 2854, 1646, 1513, 1249 cm-1; 1H-NMR
(400 MHz, CDCl3): δ 7.34-7.25 (m, 5H, Ar-H), 7.15 (m, 2H, Ar-H), 6.84 (m, 2H, Ar-H), 5.75 (s, 1H,
NH), 4.60 (d, J = 11.5 Hz, 1H, OCH2), 4.53 (d, J = 11.5 Hz, 1H, OCH2), 4.33 (dd, J = 14.4, 5.6 Hz,
1H, NCH2), 4.29 (dd, J = 14.4, 5.6 Hz, 1H, NCH2), 3.78 (s, 3H, OCH3), 3.51 (m, 1H, H-4), 3.36 (ddd,
J = 5.6, 5.6, 5.1 Hz, 1H, H-5), 2.32-2.23 (m, 2H), 2.26 (s, 1H, OH), 2.05 (m, 1H), 1.88 (ddd,
J = 14.2, 6.7, 6.7 Hz, 1H), 1.52-1.40 (m, 3H), 1.34-1.20 (m, 11H), 0.88 (t, J = 6.9 Hz, 3H, CH3); 13C-

Molecules 2010, 15
2777
NMR (100 MHz, CDCl3): δ 172.4 (C=O), 159.0, 138.3, 130.4, 129.2 (2×C), 128.4 (2×C), 127.9 (2×C),
127.8, 114.0 (2×C), 81.2 (C-5), 72.7 (C-4), 72.6 (OCH2), 55.3 (OCH3), 43.1 (NCH2), 33.4, 31.8 (2×C),
29.7, 29.5, 29.3, 26.0, 25.8, 22.6, 14.1; MS (ESI): 456 [M+H]+; Anal calcd for C28H41NO4: C, 73.85;
H, 9.01; N, 3.08. Found C, 73.59; H, 8.98; N, 3.06.
(4S,5S)-4-Benzyloxy-5-hydroxy-N-(4-methoxybenzyl)heptadecanoyl amide (syn-10f): White solid, mp:
68-70 °C; [α]25D: -2.63 (c 1.1, CHCl3); IR (film) νmax: 3423, 3305, 2924, 2853, 1643, 1513, 1248 cm-1;
1H-NMR (400 MHz, CDCl3): δ 7.35-7.23 (m, 5H, Ar-H), 7.16 (d, J = 8.2 Hz, 2H, Ar-H), 6.85 (d,
J = 8.2 Hz, 2H, Ar-H), 5.70 (s, 1H, NH), 4.61 (d, J = 11.5 Hz, 1H, OCH2), 4.54 (d, J = 11.5 Hz, 1H,
OCH2), 4.34 (dd, J = 14.5, 5.5 Hz, 1H, NCH2), 4.30 (dd, J = 14.5, 5.5 Hz, 1H, NCH2), 3.79 (s, 3H,
OCH3), 3.52 (m, 1H, H-4), 3.36 (ddd, J = 5.3, 5.3, 5.1 Hz, 1H, H-5), 2.30-2.23 (m, 2H), 2.26 (s, 1H,
OH), 2.05 (ddd, J = 14.0, 7.3, 7.3 Hz, 1H, H-2), 1.88 (ddd, J = 14.0, 7.0, 7.0 Hz, 1H, H-2), 1.52-1.40
13
(m, 3H), 1.35-1.20 (m, 19H), 0.88 (t, J = 6.6 Hz, 3H, CH3); C-NMR (100 MHz, CDCl3): δ 172.4
(C=O), 159.1, 138.3, 130.4, 129.2 (2×C), 128.5 (2×C), 127.9 (2×C), 127.8, 114.1 (2×C), 81.2 (C-5),
72.7 (C-4), 72.6 (OCH2), 55.3 (OCH3), 43.1 (NCH2), 33.5, 31.9, 31.8, 29.7 (6×C), 29.4, 26.0, 25.8,
22.7, 14.1; MS (ESI): 512 [M+H]+, 534 [M+Na]+; Anal calcd for C32H49NO4: C, 75.11; H, 9.65; N,
2.74. Found C, 75.39; H, 9.91; N, 2.86.
(4S,5S)-4-Benzyloxy-5-hydroxy-N-(4-methoxybenzyl)heneicosanoyl amide (syn-10g): White solid, mp:
62-64 °C; [α]25D: -1.93 (c 1.1, CHCl3); IR (film) νmax: 3419, 3302, 2923, 2852, 1655, 1513, 1249 cm-1;
1H-NMR (400 MHz, CDCl3): δ 7.33-7.27 (m, 5H, Ar-H), 7.17 (d, J = 8.6 Hz, 2H, Ar-H), 6.85 (d,
J = 8.6 Hz, 2H, Ar-H), 5.65 (s, 1H, NH), 4.60 (d, J = 11.5 Hz, 1H, OCH2), 4.54 (d, J = 11.5 Hz, 1H,
OCH2), 4.33 (dd, J = 14.4, 5.5 Hz, 1H, NCH2), 4.30 (dd, J = 14.4, 5.5 Hz, 1H, NCH2), 3.80 (s, 3H,
OCH3), 3.52 (m, 1H, H-4), 3.35 (m, 1H, H-5), 2.30-2.22 (br s, 1H, OH), 2.26 (t, J = 7.4 Hz, 2H, H-2),
2.05 (ddd, J = 14.1, 7.4, 7.4 Hz, 1H, H-3), 1.88 (ddd, J = 14.1, 7.4, 6.8 Hz, 1H, H-3), 1.52-1.40 (m,
3H), 1.35-1.20 (m, 27H), 0.88 (t, J = 6.8 Hz, 3H, CH3); 13C-NMR (100 MHz, CDCl3): δ 172.4 (C=O),
159.1, 138.3, 130.4, 129.2 (2×C), 128.5 (2×C), 127.9 (2×C), 127.8, 114.1 (2×C), 81.2 (C-5), 72.8 (C-
4), 72.6 (OCH2), 55.3 (OCH3), 43.1 (NCH2), 33.5, 31.9, 31.8, 29.7 (8×C), 29.6 (2×C), 29.4, 26.0, 25.8,
22.7, 14.1; MS (ESI): 568 [M+H]+; Anal calcd for C36H57NO4: C, 76.15; H, 10.12; N, 2.47. Found C,
76.51; H, 9.74; N, 2.46.
(4S,5S)-4-Benzyloxy-5-hydroxy-N-(4-methoxybenzyl)-7-methyloctanoyl amide (syn-10h): Waxy solid;
1
[α]25D: -7.34 (c 2.9, CHCl3); IR (film) νmax: 3410, 3303, 1644, 1513, 1248 cm-1; H-NMR (400 MHz,
CDCl3): δ 7.35-7.23 (m, 5H, Ar-H), 7.15 (d, J = 8.5 Hz, 2H, Ar-H), 6.85 (d, J = 8.5 Hz, 2H, Ar-H),
5.85 (s, 1H, NH), 4.59 (d, J = 11.5 Hz, 1H, OCH2), 4.53 (d, J = 11.5 Hz, 1H, OCH2), 4.33 (dd,
J = 14.4, 5.8 Hz, 1H, NCH2), 4.27 (dd, J = 14.4, 5.8 Hz, 1H, NCH2), 3.78 (s, 3H, OCH3), 3.65-3.57 (m,
1H, H-4), 3.32 (m, 1H, H-5), 2.37 (d, J = 4.9 Hz, 1H, OH), 2.25 (t, J = 7.2 Hz, 2H, H-2), 2.08-1.98 (m,
1H), 1.93-1.75 (m, 2H), 1.48-1.38 (m, 1H), 1.27-1.18 (m, 1H), 0.92 (d, J = 6.7 Hz, 3H, CH3), 0.88 (d,
J = 6.7 Hz, 3H, CH3); 13C-NMR (100 MHz, CDCl3): δ 172.4 (C=O), 158.9, 138.2, 130.3, 129.1 (2×C),
128.4 (2×C), 127.9 (2×C), 127.8, 114.0 (2×C), 81.6 (C-5), 72.6 (C-4), 70.6 (OCH2), 55.2 (OCH3), 43.0
(NCH2), 42.3, 31.8, 25.9, 24.5, 23.6, 21.7; MS (ESI): 400 [M+H]+, 422 [M+Na]+, 438 [M+K]+; Anal
calcd for C24H33NO4: C, 72.15; H, 8.33; N, 3.51. Found C, 72.19; H, 8.16; N, 3.29.

Molecules 2010, 15
2778
(4S,5S)-4-Benzyloxy-5-hydroxy-N-(4-methoxybenzyl)-5-phenylpentanoyl amide (syn-10i): White solid,
1
mp: 45-47 °C; [α]25D: +14.09 (c 2.7, CHCl3); IR (film) νmax: 3411, 3307, 1655, 1512, 1249 cm-1; H-
NMR (400 MHz, CDCl3): δ 7.36-7.23 (m, 10H, Ar-H), 7.15 (d, J = 8.6 Hz, 2H, Ar-H), 6.86 (d,
J = 8.6 Hz, 2H, Ar-H), 5.52 (s, 1H, NH), 4.83 (d, J = 6.1 Hz, 1H, H-5), 4.51 (d, J = 11.5 Hz, 1H,
OCH2), 4.46 (d, J = 11.5 Hz, 1H, OCH2), 4.28 (dd, J = 14.4, 5.6 Hz, 1H, NCH2), 4.22 (dd, J = 14.4,
5.6 Hz, 1H, NCH2), 3.77 (s, 3H, OCH3), 3.63 (ddd, J = 6.3, 6.1, 5.2 Hz, 1H, H-4), 3.06 (d, J = 4.0 Hz,
13
1H, OH), 2.13 (t, J = 7.6 Hz, 2H, H-2), 1.90 (m, 1H, H-3), 1.78 (m, 1H, H-3); C-NMR (100 MHz,
CDCl3): δ 172.3 (C=O), 159.0, 141.1, 138.0, 130.4, 129.2 (2×C), 128.5 (2×C), 128.3 (2×C), 128.1
(2×C), 127.9 (2×C), 126.8 (2×C), 114.1 (2×C), 82.6 (C-5), 75.8 (C-4), 72.0 (OCH2), 55.3 (OCH3),
43.1 (NCH2), 32.0, 26.5; MS (ESI): 420 [M+H]+, 442 [M+Na]+, 458 [M+K]+; Anal calcd for
C26H29NO4: C, 74.44; H, 6.97; N, 3.34. Found C, 74.49; H, 6.82; N, 3.59.
(4S,5S)-4-Benzyloxy-5-hydroxy-N-(4-methoxybenzyl)-6-phenylhexanoyl amide (syn-10j): Waxy solid;
1
[α]25D: +2.01 (c 2.6, CHCl3); IR (film) νmax: 3403, 3305, 1644, 1513, 1248, 1030 cm-1; H-NMR (400
MHz, CDCl3): δ 7.35-7.23 (m, 8H, Ar-H), 7.17-7.12 (m, 4H, Ar-H), 6.83 (d, J = 8.7 Hz, 2H, Ar-H),
5.55 (s, 1H, NH), 4.61 (d, J = 11.5 Hz, 1H, OCH2), 4.54 (d, J = 11.5 Hz, 1H, OCH2), 4.30 (dd,
J = 14.5, 5.6 Hz, 1H, NCH2), 4.25 (dd, J = 14.5, 5.6 Hz, 1H, NCH2), 3.82-3.75 (m, 1H, H-4), 3.75 (s,
3H, OCH3), 3.39 (ddd, J = 5.8, 5.8, 5.1 Hz, 1H, H-5), 2.85 (dd, J = 13.8, 4.8 Hz, 1H, H-6), 2.75 (dd, J
= 13.8, 8.3 Hz, 1H, H-6), 2.45 (d, J = 5.8 Hz, 1H, OH), 2.23 (t, J = 7.3 Hz, 2H, H-2), 2.07 (ddd,
13
J = 14.0, 7.3, 5.6 Hz, 1H, H-3), 1.93 (ddd, J = 14.0, 7.3, 7.0 Hz, 1H, H-3); C-NMR (100 MHz,
CDCl3): δ 172.4 (C=O), 158.9, 138.6, 138.2, 130.3, 129.3 (2×C), 129.1 (2×C), 128.4 (4×C), 128.0
(2×C), 127.8, 126.3, 114.0 (2×C), 79.8 (C-5), 73.6 (C-4), 72.2 (OCH2), 55.2 (OCH3), 43.0 (NCH2),
39.7, 31.9, 25.7; MS (ESI): 434 [M+H]+, 456 [M+Na]+, 472 [M+K]+; Anal calcd for C27H31NO4: C,
74.80; H, 7.21; N, 3.23. Found C, 74.83; H, 7.55; N, 3.28.
(4S,5S)-4-Benzyloxy-5-hydroxy-N-(4-methoxybenzyl)-7-phenylheptanoyl amide (syn-10k): Waxy solid.
1
[α]25D: -7.35 (c 1.9, CHCl3); IR (film) νmax: 3411, 3306 2932, 1645, 1513, 1248, 1030 cm-1; H-NMR
(400 MHz, CDCl3): δ 7.40-7.20 (m, 10H, Ar-H), ,7.15 (d, J = 8.6 Hz, 2H, Ar-H), 6.85 (d, J = 8.6 Hz,
;2H, Ar-H), 5.63 (s, 1H, NH), 4.50 (d, J = 11.5 Hz, 1H, OCH2), 4.47 (d, J = 11.5 Hz, 1H, OCH2), 4.33
(dd, J = 14.5, 5.6 Hz, 1H, NCH2), 4.25 (dd, J = 14.5, 5.6 Hz, 1H, NCH2), 3.78 (s, 3H, OCH3), 3.71 (m,
1H, H-4), 3.37 (m, 1H, H-5), 2.90 (m, 2H), 2.67 (ddd, J = 13.8, 9.5, 7.0 Hz, 1H, H-3), 2.38 (d,
J = 7.6 Hz, 2H, H-2), 2.52 (d, J = 5.6 Hz, 1H, OH), 2.08 (ddd, J = 13.8, 7.6, 5.2 Hz, 1H, H-3), 1.93-
13
1.78 (m, 2H); C-NMR (100 MHz, CDCl3): δ 172.9 (C=O), 159.0, 142.1, 138.0, 130.2, 129.4, 129.2
(2×C), 128.5, 128.1 (4×C), 128.0 (2×C), 127.8, 125.5, 114.0 (2×C), 81.2 (C-5), 72.5 (C-4), 70.3
(OCH2), 55.1 (OCH3), 43.1 (NCH2), 34.9, 32.1, 31.7, 23.3; MS (ESI): 448 [M+H]+, 470 [M+Na]+;
Anal calcd for C28H33NO4: C, 75.14; H, 7.43; N, 3.13. Found C, 75.23; H, 7.75; N, 3.39.
4.3. The synthesis of (5S,6R)-2-Piperidinone 8a via the cyclization of 10a
To a cooled (−20 °C) solution of a mixture of 10a (182 mg, 0.51 mmol) and Et3N (0.14 mL,
1.00 mmol) in CH2Cl2 (5 mL) was added dropwise MsCl (0.047 mL, 0.61 mmol) under a nitrogen

Molecules 2010, 15
2779
atmosphere. The mixture was stirred at −20 ~ −10 °C for 1 h. Water was added and the aqueous layer
was separated and extracted with CH2Cl2. The combined organic layers were washed with brine, dried
over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified
by flash chromatography on silica gel (eluent: EtOAc/P.E. = 1:2) to yield the mesylate 11 (202 mg),
which is unstable and was used immediately in the next step. To a solution of mesylate 11 (202 mg,
0.43 mmol) in THF (3 mL) and HMPA (0.15 mL, 0.86 mmol) was added dropwise a solution of
potassium tert-butoxide (58 mg, 0.52 mmol) in THF (2 mL) at 0 °C under nitrogen atmosphere. The
mixture was allowed slowly warming to room temperature and was stirred for 24 h. The reaction was
quenched with saturated NH4Cl at 0 °C. The aqueous layer was separated and extracted with CH2Cl2.
The combined organic layers were washed with brine, dried over anhydrous Na2SO4, filtered, and
concentrated under reduced pressure. The residue was purified by flash chromatography on silica gel
(eluent EtOAc/P.E. = 1:2) to yield (5S,6R)-8a (135 mg, 78% yield). For the data of (5S,6R)-8a see [20].
Acknowledgements
The authors are grateful to the NSF of China (No: 20772099) and Natural Science Foundation of
Jiangxi Province (No: 2009GZH0013) for financial support.
References and Notes
1. Ratnayake, A.S.; Yoshida, W.Y.; Moonberry, S.L.; Hemscheidt, T. The structure of Microcar-
palide, a Microfilament disrupting agent from an endophytic fungus. Org. Lett. 2001, 3,
3479-3481.
2. Costa, S.S.; Souza, M.L.M.; Ibrahim, T.; Melo, G.O.; Almeida, A.P.; Guette, C.; Férézou, J.P.;
Koatz, V.L.G. Kalanchosine dimalate, an anti-inflammatory salt from Kalanchoe brasiliensis. J
.Nat. Prod. 2006, 69, 815-818.
3. Mcinerney, B.V. Biologically active metabolites from xenorhabdus spp. Part 2. Benzopyran-1-one
derivatives with gastroprotective activity. J. Nat. Prod. 1991, 54, 785-795.
4. Enomoto, M.; Kuwahara, S.; Concise synthesis of PM-94128 and Y-05460M-A. J. Org. Chem.
2009, 74, 7566-7599.
5. Shimojima, Y.; Hayashi, H.; Ooka, T.; Shibukawa, M.; Iitaka, Y. Studies on AI-77s, microbial
products with gastroprotective activity. Structures and the chemical nature of AI-77s. Tetrahedron
1984, 40, 2519-2527.
6. Shimojima, Y.; Shirai, T.; Baba, T.; Hayashi, H. 1H-2-Benzopyran-1-one derivatives, microbial
products with pharmacological activity. Conversion into orally active derivatives with
antiinflammatory and antiulcer activities. J. Med. Chem. 1985, 28, 3-9.
7. Shimojima, Y.; Hayashi, H. 1H-2-Benzopyran-1-one derivatives, microbial products with
pharmacological activity. Relationship between structure and activity in [[1(S)-(3(S), 4-dihydro-8-
hydroxy-l-oxo-1H-2-benzopyran-3-yl)-3-methylbutylamino]-4(S),5(S)-dihydroxy-6-oxo-3(S)-
ammoniohexanoate. J. Med. Chem. 1983, 26, 1370-1374.
8. Murga, J.; Falomir, E.; Garcoa-Fortanet, J.; Carda, M.; Marco, J.A. Stereoselective synthesis of
Microcarpalide. Org. Lett. 2002, 4, 3447-3449.

Molecules 2010, 15
2780
9. Gurjar, M.K.; Nagaprasad, R.; Ramana, C.V. Total synthesis of microcarpalide. Tetrahedron Lett.
2003, 44, 2873-2875.
10. Banwell, M.G.; Loong, D.T.J. Stereoselective total synthesis of the nonenolide (+)-
microcarpalide. Heterocycles 2004, 62, 713-734.
11. Gurjar, M.K.; Nagaprasad, R.; Ramana, C.V.; Karmakar, S.; Moha patra, D.K. Ring-closing
metathesis mediated total synthesis of microcarpalide and herbarumin III. ARKIVOC 2005 (iii),
237-257.
12. García-Fortanet, J.; Murga, J.; Falomir, E.; Carda, M.; Marco, J.A. Stereoselective total synthesis
and absolute configuration of the natural decanolides (-)-Microcarpalide and (+)-Lethaloxin.
Identity of (+)-Lethaloxin and (+)-Pinolidoxin. J .Org. Chem. 2005, 70, 9822-9827.
13. Ghosh, S.; Rao, R.V.; Shashidhar, J. Total synthesis of (-)-microcarpalide from D-mannitol.
Tetrahedron Lett. 2005, 46, 5479-5481.
14. Ishigami, K.; Kitahara, T. Synthesis of microcarpalide, a microfilament disrupting agent.
Heterocycles 2004, 63, 785-790.
15. Ishigami, K.; Watanabe, H.; Kitahara, T. Stereoselective synthesis of microcarpalide. Tetrahedron
2005, 61, 7546-7553.
16. Davoli, P.; Fava, R.; Morandi, S.; Spaggiari, A.; Prati, F. Enantioselective total synthesis of (-)-
microcarpalide. Tetrahedron 2005, 61, 4427-4436.
17. Chavan, S.P.; Praveen, C. Stereoselective synthesis of (-)-microcarpalide. Tetrahedron Lett. 2005,
46, 1939-1941.
18. Kumar, P.; Naidu, S.V. Total synthesis of microcarpalide. J. Org. Chem. 2005, 70, 4207-4210.
19. Huang, P.-Q.; Liu, L.-X.; Wei, B.-G.; Ruan, Y.-P. Asymmetric synthesis of (+)-L-733,060 and
(+)-CP-99,994 based on a new chiral 3-piperidinol synthon. Org. Lett. 2003, 5, 1927-1930.
20. Liu, L.-X.; Ruan, Y.-P.; Guo, Z.-Q.; Huang, P.-Q. A general approach to (5S,6R)-6-alkyl-5-
benzyloxy-2-piperidinones: application to the asymmetric syntheses of neurokinin substance P
peceptor antagonist (-)-L-733,061 and (-)-deoxocassine. J. Org. Chem. 2004, 69, 6001-6009.
21. Liu, L.-X.; Huang, P.-Q. SN2 reaction of 2-substituted 3-piperidinol mesylate with retention of
conguration: application to the asymmetric synthesis of (2R,3S)-CP-99,994. Tetrahedron:
Asymmetry 2006, 17, 3265-3272.
22. Liu, L.-X.; Pen, Q.-L.; Huang, P.-Q. A new approach for the asymmetric syntheses of (2S,3S)-3-
hydroxypipercolic acid. Tetrahedron Asymmetry 2008, 19, 1200-1203.
23. Yu, D.-S.; Xu, W.-X.; Liu, L.-X.; Huang, P.-Q. First asymmetric synthesis of piperidine alkaloid
(-)-morusimic acid. Synlett 2008, 1189-1192.
24. Liu, L.-X.; Xiao, K.J.; Huang, P.-Q. Chemo- and diastereoselective control for a flexible approach
to (5S,6S)-6-alkyl-5-benzyloxy-2-piperidinones. Tetrahedron 2009, 65, 3834-3841.
25. Xiao, K.J.; Liu, L.-X.; Huang, P.-Q. An enantioselective of synthesis of (+)-azimic acid.
Tetrahedron Asymmetry 2009, 20, 1181-1184.
26. García Ruano, J.L.; Fernández-Ibáñez, M.Ά.; Maestro, M.C.; Rodríguez-Fernández, M.M. Remote
stereocontrol by sulfinyl groups: reduction of δ-ketosulfoxides. J. Org. Chem. 2005, 70,
1796-1801.

Molecules 2010, 15
2781
27. Bahia, P.S.; Snaith, J.S. Synthesis of 3-substituted 4-piperidinones via a one-pot Tandem
oxidation-cyclization-oxidation process: stereodivergent reduction to 3,4-disubstituted piperidines.
J. Org. Chem. 2004, 69, 3226-3229.
28. Colyer, J.T.; Andersen, N.G.; Tedrow, J.S.; Soukup, T.S.; Faul, M.M. Reversal of diastereofacial
selectivity in hydride reductions of N-tert-butanesulfinyl imines. J. Org. Chem. 2006, 71,
6859-6862.
29. Ripoche, I.; Bennis, K.; Canet, J.-L.; Gelas, J.; Troin, Y. Diastereoselective elaboration of 2,3,4-
substituted piperidines using diene iron tricarbonyl complexes. Total synthesis of (±)-dienomycin
C and (±)-4-epi-dienomycin C. Tetrahedron Lett. 1996, 37, 3991-3992.
30. Mohanta, P.K.; Davis, T.A.; Gooch, J.R.; Flowers,II, R.A. Chelation-controlled diastereoselective
reduction of α-fluoroketones. J. Am. Chem. Soc. 2005, 127, 11896-11897.
31. Andrés, J.M.; Barrio, R.; .Martínez, M.A.; Pedrosa, R.; Pérez-Encabo, A. Synthesis of
enantiopure syn-β-amino alcohols. A simple case of chelation-controlled additions of diethylzinc
to α-(dibenzylamino) aldehydes. J. Org. Chem. 1996, 61, 4210-4213.
32. Marco, J.A.; Carda, M.; González, F.; Rodríguez, S.; Castillo, E.; Murga, J. J. Org. Chem. 1998,
63, 698-707.
33. Cram, D.J.; Abd Elhafez, F.A. Studies in stereochemistry. X. The rule of “steric control of
asymmetric induction” in the syntheses of acyclic systems. J. Am. Chem. Soc. 1952, 74,
5828-5835.
34. Cram, D.J.; Kopecky, K.R. Studies in stereochemistry. XXX. models for steric control of
asymmetric. J. Am. Chem. Soc. 1959, 81, 2748-2755.
Sample Availability: Samples of the compounds 10a-10k are available from the authors.
© 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.
This article is an open-access article distributed under the terms and conditions of the Creative
Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).